Joseph M. Sutton

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty

J. Kereiakes, Neal S. Kleiman, John A. Ambrose et al. · Journal of the American College of Cardiology · 1996 · 225 citations · Full text

Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group.

Joseph M. Sutton, Sam Ellis, Gary S. Roubin et al. · Circulation · 1994 · 140 citations

First Chronic Platelet Glycoprotein IIb/IIIa Integrin Blockade

Conrad Simpfendorfer, Kandice Kottke‐Marchant, Marsha Lowrie et al. · Circulation · 1997 · 116 citations

Positive Screening Tests for Gonorrhea and Chlamydial Infection Fail to Lead Consistently to Treatment of Patients Attending a Sexually Transmitted Disease Clinic

Jane R. Schwebke, R. Mark Sadler, Joseph M. Sutton et al. · Sexually Transmitted Diseases · 1997 · 75 citations

Usefulness of Technetium-99m Sestamibi Infarct Size in Predicting Posthospital Mortality Following Acute Myocardial Infarction

Todd D. Miller, David O. Hodge, Joseph M. Sutton et al. · The American Journal of Cardiology · 1998 · 59 citations

Thrombosis, Cardiovascular Disease, Myocardial Infarction +8